Transvaginal mesh (TVM) surgeries emerged as an innovative treatment for stress urine incontinency and/or pelvic organ prolapse in 1996. Years after rapid adoption of these surgeries into practice, they are a key example of worldwide failure of healthcare quality and patient safety. The prevalence of TVM-associated harms eventually prompted action globally, including an Australian Commonwealth Government Senate Inquiry in 2017.
The post Patients’ perspectives on quality and patient safety failures: lessons learned from an inquiry into transvaginal mesh in Australia – Mina Motamedi, Chris Degeling & Stacy M Carter appeared first on Wiser Healthcare.
